Insider buying last 90 days
No open-market insider purchases were filed for BN in the last 90 days.
From Form 4 filings, dated to when each was filed.
Close on Sep 18, 2026. Page updated Sep 19, 9:18 pm ET.
Brookfield (BN) closes at $37.51, down 0.9% [sic] on the day, and sits below both its 50-day average of $41.74 and its 200-day average of $43.96, with the stock recently touching a new 52-week low of $37.02. The GekkoIndex reads 72.9, placing BN in the Buying zone, while shares trade 19.9% below the Gekko Fair Value estimate of $46.80. Over the past year the stock is down 18.9%, with a three-month return of -15.6% and a one-month return of -11%.
This week's coverage centers on Brookfield's Investor Day, where Brookfield Asset Management outlined plans to double fee-bearing capital by 2031, alongside discussion of Brookfield Corporation's Q2 distributable earnings before realizations of $1.4 billion, up 15% year-over-year, and $77 billion raised in the quarter. Separately, Brookfield Infrastructure reported data center FFO up 36% and midstream up 17%, and Reliance Worldwide agreed to a buyout from Brookfield valued at roughly $2.9 billion.
BN's next earnings report is scheduled for 12 November 2026, 53 days out, placing it outside a typical 20-trading-day holding window; the prior report on 13 August showed EPS of $0.60 against a $0.62 estimate, with a -1.9% reaction, and one beat over the last seven quarters. Seasonality over the next 20 trading days has averaged -2.2% across 5 years, rising in 2 of those years. No insider, Congress, or unusual options activity appears in the current windows, while three billionaire holders are recorded, and analyst consensus places a target of $54.40, implying 45% upside.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Brookfield scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
Below 50 and 200-day
Close $37.51 is below the 50-day ($41.74) and 200-day ($43.96) averages, and the 50-day is below the 200-day.
See the chart72.9, Buying
Reading 72.9 is in the Buying zone.
See the GekkoIndex19.9% below
Price is 19.9% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 53 days
Next report Nov 12, 2026, 53 days away — outside a typical 20-trading-day hold.
See earnings−2.2% on average
From this point in the calendar, the next 20 trading days averaged −2.2% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Brookfield closed at $37.51 on Sep 18, 2026, −18.9% over the past year, inside a 52-week range of $36.67 to $49.57.
Use the left and right arrow keys to read daily values.
Put BN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Brookfield’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 72.9, in the Buying zone, down 2.2 points over five sessions.
Down 2.2 points over five sessions.
Reading for Sep 18, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying (current zone) | 23 | +1.8% | +4.9% | ||
| Accumulation | 160 | +0.4% | +4.4% | ||
| Neutral | 446 | +0.5% | +0.8% | ||
| Distribution | 26 | −1.9% | −2.8% | ||
| Selling | 7 | Too few readings yet | |||
Average BN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Buying readings averaged +3.2% over 20 days. Past behaviour doesn’t guarantee future results.
Buying zone: Smart money likely accumulating heavily. About the five zones →
Brookfield trades 19.9% below Gekko Fair Value of $46.80, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Brookfield shares are worth, recalculated every trading day.
$46.80
Gekko Fair Value, Sep 19, 2026
19.9% Undervalued
No open-market insider purchases were filed for Brookfield, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for BN in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in BN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Brookfield has been buying back its own shares.
From company filings.
3of the funds Gekko tracks hold BN.
Brookfield reports on Nov 12, 2026 (53 days away), and beat the EPS estimate in 1 of its last 7 reports.
Nov 12, 2026
53 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 13, 2026 | $0.60 est $0.62 | $1.62B est $1.66B | −1.9% |
| May 14, 2026 | $0.03 | $1.63B est $1.62B | +1.0% |
| Feb 12, 2026 | $0.30 est $0.60 | $1.71B est $1.63B | +2.5% |
| Nov 13, 2025 | $0.56 est $0.39 | $18.92B est $11.77B | −6.1% |
| Aug 7, 2025 | $0.10 est $0.90 | $18.08B est $1.44B | −4.1% |
| May 8, 2025 | $0.02 est $0.86 | $17.94B est $1.36B | +1.4% |
| Feb 13, 2025 | $0.25 est $0.87 | — | +4.0% |
| Nov 14, 2024 | $0.01 est $0.82 | $20.62B est $1.30B | −1.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Brookfield is $54.40, +45.0% from the last close.
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 19, Brookfield averaged −2.2% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −3.0% | 2 of 5 |
| Next 10 trading days | −4.5% | 2 of 5 |
| Next 15 trading days | −4.5% | 2 of 5 |
| Next 20 trading days | −2.2% | 2 of 5 |
| Next 30 trading days | −3.1% | 2 of 5 |
For scale, BN’s typical 20-trading-day move in either direction is about 5.7%.
Brookfield’s market cap is $83.78B, with a P/E ratio of 68.9 and revenue of $80.69B over the last twelve months.
6 headlines about Brookfield from the past week, newest first, each linking to the publisher.
Brookfield’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSMorgan Stanley | Accumulation | 9.3% below |
| UBSUBS | Accumulation | 6.1% below |
| BLKBlackRock | Accumulation | 10.3% below |
| BXBlackstone | Accumulation | 9.5% below |
| KKRKKR | Accumulation | 13.2% below |
| BAMBrookfield Asset Management | Buying | 12.7% below |
A peer links to its own page where one exists.
Brookfield’s market cap is $83.78B at the Sep 18, 2026 close of $37.51, with 2.23B shares outstanding. The shares trade on a P/E ratio of 68.9.
The consensus analyst 12-month price target for Brookfield is $54.40, +45.0% from the last close. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Brookfield is undervalued: the Sep 18, 2026 close of $37.51 is 19.9% below Gekko Fair Value of $46.80. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Brookfield is expected to report on Nov 12, 2026 (53 days away). Analysts expect earnings of $0.70 per share on revenue of $1.80B. Brookfield beat the earnings estimate in 1 of its last 7 reports, moving 2.8% on average across the report.
Brookfield’s 52-week high is $49.57 and its 52-week low is $36.67; it closed at $37.51 on Sep 18, 2026, −18.9% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.